{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:57:02Z","timestamp":1791687422659,"version":"4.3.4"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T00:00:00Z","timestamp":1652486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T00:00:00Z","timestamp":1652486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["National Institute of Health\/National Cancer Institute (grant number P30CA008748)."],"award-info":[{"award-number":["National Institute of Health\/National Cancer Institute (grant number P30CA008748)."]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00428-022-03299-3","type":"journal-article","created":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T09:06:56Z","timestamp":1652519216000},"page":"823-837","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The morphologic spectrum of lobular carcinoma in situ (LCIS) observations on clinical significance, management implications and diagnostic pitfalls of classic, florid and pleomorphic LCIS"],"prefix":"10.1007","volume":"481","author":[{"given":"Edi","family":"Brogi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,14]]},"reference":[{"key":"3299_CR1","unstructured":"WHO (2019) Classification of Tumours Editorial Board. Breast Tumours. 5th ed. IARC, Lyon, France"},{"issue":"2","key":"3299_CR2","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/1097-0142(197808)42:2<737::AID-CNCR2820420247>3.0.CO;2-T","volume":"42","author":"CD Haagensen","year":"1978","unstructured":"Haagensen CD, Lane N, Lattes R, Bodian C (1978) Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer. 42(2):737\u2013769","journal-title":"Cancer."},{"issue":"12","key":"3299_CR3","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/0046-8177(91)90105-X","volume":"22","author":"DL Page","year":"1991","unstructured":"Page DL, Kidd TE Jr, Dupont WD, Simpson JF, Rogers LW (1991) Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol. 22(12):1232\u20131239","journal-title":"Hum Pathol."},{"issue":"11","key":"3299_CR4","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1002\/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0.CO;2-A","volume":"55","author":"DL Page","year":"1985","unstructured":"Page DL, Dupont WD, Rogers LW, Rados MS (1985) Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 55(11):2698\u20132708","journal-title":"Cancer"},{"issue":"4","key":"3299_CR5","first-page":"491","volume":"17","author":"FW Foote","year":"1941","unstructured":"Foote FW, Stewart FW (1941) Lobular carcinoma in situ: A rare form of mammary cancer. Am J Pathol 17(4):491\u2013463","journal-title":"Am J Pathol"},{"issue":"2","key":"3299_CR6","doi-asserted-by":"publisher","first-page":"M74","DOI":"10.1136\/mp.48.2.M74","volume":"48","author":"SR Lakhani","year":"1995","unstructured":"Lakhani SR, Collins N, Sloane JP, Stratton MR (1995) Loss of heterozygosity in lobular carcinoma in situ of the breast. Clin Mol Pathol 48(2):M74\u2013M78","journal-title":"Clin Mol Pathol"},{"issue":"20","key":"3299_CR7","first-page":"4721","volume":"58","author":"YJ Lu","year":"1998","unstructured":"Lu YJ, Osin P, Lakhani SR, Di Palma S, Gusterson BA, Shipley JM (1998) Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia. Cancer Res 58(20):4721\u20134727","journal-title":"Cancer Res"},{"issue":"4","key":"3299_CR8","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/(SICI)1096-9896(199712)183:4<404::AID-PATH1148>3.0.CO;2-9","volume":"183","author":"WJ De Leeuw","year":"1997","unstructured":"De Leeuw WJ, Berx G, Vos CB, Peterse JL, Van de Vijver MJ, Litvinov S et al (1997) Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 183(4):404\u2013411","journal-title":"J Pathol"},{"issue":"9","key":"3299_CR9","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/bjc.1997.523","volume":"76","author":"CB Vos","year":"1997","unstructured":"Vos CB, Cleton-Jansen AM, Berx G, de Leeuw WJ, ter Haar NT, van Roy F et al (1997) E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer 76(9):1131\u20131133","journal-title":"Br J Cancer"},{"issue":"2","key":"3299_CR10","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.cell.2015.09.033","volume":"163","author":"G Ciriello","year":"2015","unstructured":"Ciriello G, Gatza ML, Beck AH, Wilkerson MD, Rhie SK, Pastore A et al (2015) Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell 163(2):506\u2013519","journal-title":"Cell"},{"issue":"2","key":"3299_CR11","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/ijc.11197","volume":"106","author":"D Sarrio","year":"2003","unstructured":"Sarrio D, Moreno-Bueno G, Hardisson D, Sanchez-Estevez C, Guo M, Herman JG et al (2003) Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability. Int J Cancer 106(2):208\u2013215","journal-title":"Int J Cancer"},{"key":"3299_CR12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.humpath.2016.05.003","volume":"55","author":"Y Wang","year":"2016","unstructured":"Wang Y, Jindal S, Martel M, Wu Y, Schedin P, Troxell M (2016) Myoepithelial cells in lobular carcinoma in situ: distribution and immunophenotype. Hum Pathol 55:126\u2013134","journal-title":"Hum Pathol"},{"key":"3299_CR13","doi-asserted-by":"crossref","unstructured":"Sgroi D, Koerner FC (1995) Involvement of collagenous spherulosis by lobular carcinoma in situ. Potential confusion with cribriform ductal carcinoma in situ. Am J Surg Pathol 19(12):1366\u20131370","DOI":"10.1097\/00000478-199512000-00004"},{"issue":"33","key":"3299_CR14","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1200\/JCO.2015.61.4743","volume":"33","author":"TA King","year":"2015","unstructured":"King TA, Pilewskie M, Muhsen S, Patil S, Mautner SK, Park A et al (2015) Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk. J Clin Oncol 33(33):3945\u20133952","journal-title":"J Clin Oncol"},{"issue":"9","key":"3299_CR15","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1245\/s10434-017-5867-6","volume":"24","author":"SM Wong","year":"2017","unstructured":"Wong SM, King T, Boileau JF, Barry WT, Golshan M (2017) Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ. Ann Surg Oncol 24(9):2509\u20132517","journal-title":"Ann Surg Oncol"},{"key":"3299_CR16","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.breast.2021.07.020","volume":"59","author":"MC van Maaren","year":"2021","unstructured":"van Maaren MC, Avila AO, van Manen JG, Menke-Pluijmers MB, Veltman J, Bart J et al (2021) Trends in incidence, treatment, survival and subsequent breast cancer in lobular carcinoma in situ in the Netherlands: A population-based analysis. Breast 59:376\u2013382","journal-title":"Breast"},{"issue":"4","key":"3299_CR17","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1158\/1055-9965.EPI-04-0849","volume":"14","author":"CI Li","year":"2005","unstructured":"Li CI, Daling JR, Malone KE (2005) Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001. Cancer Epidemiol Biomarkers Prev 14(4):1008\u20131011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"3299_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1023\/A:1019950918046","volume":"75","author":"CI Li","year":"2002","unstructured":"Li CI, Anderson BO, Daling JR, Moe RE (2002) Changing incidence of lobular carcinoma in situ of the breast. Breast Cancer Res Treat 75(3):259\u2013268","journal-title":"Breast Cancer Res Treat"},{"issue":"61","key":"3299_CR19","doi-asserted-by":"publisher","first-page":"103047","DOI":"10.18632\/oncotarget.21461","volume":"8","author":"P Cheng","year":"2017","unstructured":"Cheng P, Huang Q, Shou J, Hu G, Han M, Huang J (2017) Treatment and survival outcomes of lobular carcinoma in situ of the breast: a SEER population based study. Oncotarget 8(61):103047\u2013103054","journal-title":"Oncotarget"},{"issue":"8","key":"3299_CR20","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1245\/s10434-018-6495-5","volume":"25","author":"LJ Taylor","year":"2018","unstructured":"Taylor LJ, Steiman J, Schumacher JR, Wilke LG, Greenberg CC, Neuman HB (2018) Surgical Management of Lobular Carcinoma In Situ: Analysis of the National Cancer Database. Ann Surg Oncol 25(8):2229\u20132234","journal-title":"Ann Surg Oncol"},{"key":"3299_CR21","doi-asserted-by":"crossref","unstructured":"Rosen PP, Kosloff C, Lieberman PH, Adair F, Braun DW, Jr (1978) Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol 2(3):225\u2013251","DOI":"10.1097\/00000478-197809000-00001"},{"issue":"1","key":"3299_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0277-5379(91)90055-I","volume":"27","author":"B Salvadori","year":"1991","unstructured":"Salvadori B, Bartoli C, Zurrida S, Delledonne V, Squicciarini P, Rovini D et al (1991) Risk of invasive cancer in women with lobular carcinoma in situ of the breast. Eur J Cancer 27(1):35\u201337","journal-title":"Eur J Cancer"},{"key":"3299_CR23","doi-asserted-by":"crossref","unstructured":"Ottesen GL, Graversen HP, Blichert-Toft M, Zedeler K, Andersen JA (1993) Lobular carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. The Danish Breast Cancer Cooperative Group. Am J Surg Pathol 17(1):14\u201321","DOI":"10.1097\/00000478-199301000-00002"},{"issue":"9352","key":"3299_CR24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0140-6736(03)12230-1","volume":"361","author":"DL Page","year":"2003","unstructured":"Page DL, Schuyler PA, Dupont WD, Jensen RA, Plummer WD Jr, Simpson JF (2003) Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet 361(9352):125\u2013129","journal-title":"Lancet"},{"issue":"4","key":"3299_CR25","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/cncr.29775","volume":"122","author":"LC Collins","year":"2016","unstructured":"Collins LC, Aroner SA, Connolly JL, Colditz GA, Schnitt SJ, Tamimi RM (2016) Breast cancer risk by extent and type of atypical hyperplasia: An update from the Nurses\u2019 Health Studies. Cancer 122(4):515\u2013520","journal-title":"Cancer"},{"issue":"2","key":"3299_CR26","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/cncr.22408","volume":"109","author":"LC Collins","year":"2007","unstructured":"Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ (2007) Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses\u2019 Health Study. Cancer 109(2):180\u2013187","journal-title":"Cancer"},{"issue":"19","key":"3299_CR27","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1002\/cncr.30151","volume":"122","author":"AC Degnim","year":"2016","unstructured":"Degnim AC, Visscher DW, Radisky DC, Frost MH, Vierkant RA, Frank RD et al (2016) Breast cancer risk by the extent and type of atypical hyperplasia. Cancer 122(19):3087\u20133088","journal-title":"Cancer"},{"key":"3299_CR28","unstructured":"NCCN guidelines2021 May 1, 2021. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf"},{"issue":"1","key":"3299_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1470-2045(14)71171-4","volume":"16","author":"J Cuzick","year":"2015","unstructured":"Cuzick J, Sestak I, Cawthorn S, Hamed H, Holli K, Howell A et al (2015) Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial. Lancet Oncol 16(1):67\u201375","journal-title":"Lancet Oncol"},{"issue":"10218","key":"3299_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0140-6736(19)32955-1","volume":"395","author":"J Cuzick","year":"2020","unstructured":"Cuzick J, Sestak I, Forbes JF, Dowsett M, Cawthorn S, Mansel RE et al (2020) Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial. Lancet 395(10218):117\u2013122","journal-title":"Lancet"},{"issue":"25","key":"3299_CR31","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1056\/NEJMoa1103507","volume":"364","author":"PE Goss","year":"2011","unstructured":"Goss PE, Ingle JN, Ales-Martinez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J et al (2011) Exemestane for breast-cancer prevention in postmenopausal women. N Engl J Med 364(25):2381\u20132391","journal-title":"N Engl J Med"},{"issue":"18","key":"3299_CR32","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","volume":"90","author":"B Fisher","year":"1998","unstructured":"Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM et al (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90(18):1371\u20131388","journal-title":"J Natl Cancer Inst"},{"key":"3299_CR33","doi-asserted-by":"crossref","unstructured":"Rageth CJ, O'Flynn EAM, Pinker K, Kubik-Huch RA, Mundinger A, Decker T, et al. (2019) Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions). Breast Cancer Res Treat 174(2):279\u2013296","DOI":"10.1007\/s10549-018-05071-1"},{"issue":"8","key":"3299_CR34","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.crad.2018.04.004","volume":"73","author":"SE Pinder","year":"2018","unstructured":"Pinder SE, Shaaban A, Deb R, Desai A, Gandhi A, Lee AHS et al (2018) NHS Breast Screening multidisciplinary working group guidelines for the diagnosis and management of breast lesions of uncertain malignant potential on core biopsy (B3 lesions). Clin Radiol 73(8):682\u2013692","journal-title":"Clin Radiol"},{"issue":"5","key":"3299_CR35","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1002\/cncr.27841","volume":"119","author":"MP Murray","year":"2013","unstructured":"Murray MP, Luedtke C, Liberman L, Nehhozina T, Akram M, Brogi E (2013) Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: outcomes of prospective excision. Cancer 119(5):1073\u20131079","journal-title":"Cancer"},{"issue":"4","key":"3299_CR36","doi-asserted-by":"publisher","first-page":"929","DOI":"10.2214\/AJR.11.8447","volume":"199","author":"B Niell","year":"2012","unstructured":"Niell B, Specht M, Gerade B, Rafferty E (2012) Is excisional biopsy required after a breast core biopsy yields lobular neoplasia? AJR Am J Roentgenol 199(4):929\u2013935","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"3299_CR37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1309\/AJCPYG48TUTFIBMR","volume":"138","author":"C Zhao","year":"2012","unstructured":"Zhao C, Desouki MM, Florea A, Mohammed K, Li X, Dabbs D (2012) Pathologic findings of follow-up surgical excision for lobular neoplasia on breast core biopsy performed for calcification. Am J Clin Pathol 138(1):72\u201378","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"3299_CR38","doi-asserted-by":"publisher","first-page":"927","DOI":"10.5858\/arpa.2012-0297-OA","volume":"137","author":"TM D'Alfonso","year":"2013","unstructured":"D\u2019Alfonso TM, Wang K, Chiu YL, Shin SJ (2013) Pathologic upgrade rates on subsequent excision when lobular carcinoma in situ is the primary diagnosis in the needle core biopsy with special attention to the radiographic target. Arch Pathol Lab Med 137(7):927\u2013935","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"3299_CR39","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.clbc.2016.06.003","volume":"16","author":"B Susnik","year":"2016","unstructured":"Susnik B, Day D, Abeln E, Bowman T, Krueger J, Swenson KK et al (2016) Surgical Outcomes of Lobular Neoplasia Diagnosed in Core Biopsy: Prospective Study of 316 Cases. Clin Breast Cancer 16(6):507\u2013513","journal-title":"Clin Breast Cancer"},{"issue":"5","key":"3299_CR40","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.2214\/AJR.15.15425","volume":"207","author":"LQ Sen","year":"2016","unstructured":"Sen LQ, Berg WA, Hooley RJ, Carter GJ, Desouki MM, Sumkin JH (2016) Core Breast Biopsies Showing Lobular Carcinoma In Situ Should Be Excised and Surveillance Is Reasonable for Atypical Lobular Hyperplasia. AJR Am J Roentgenol 207(5):1132\u20131145","journal-title":"AJR Am J Roentgenol"},{"issue":"10","key":"3299_CR41","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1245\/s10434-012-2534-9","volume":"19","author":"MG Shah-Khan","year":"2012","unstructured":"Shah-Khan MG, Geiger XJ, Reynolds C, Jakub JW, Deperi ER, Glazebrook KN (2012) Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia\/lobular carcinoma in situ) diagnosed on core needle biopsy. Ann Surg Oncol 19(10):3131\u20133138","journal-title":"Ann Surg Oncol"},{"key":"3299_CR42","unstructured":"American Society Breast Surgeons. Consensus Guideline on Concordance Assessment of Image-Guided Breast Biopsies and Management of Borderline or High-Risk Lesions.\u00a0https:\/\/www.breastsurgeons.org\/docs\/statements\/Consensus-Guideline-on-Concordance-Assessment-of-Image-Guided-Breast-Biopsies.pdf?v22016. Accessed 10 Mar 2022"},{"key":"3299_CR43","doi-asserted-by":"crossref","unstructured":"Falomo E, Adejumo C, Carson KA, Harvey S, Mullen L, Myers K (2019) Variability in the Management Recommendations Given for High-risk Breast Lesions Detected on Image-guided Core Needle Biopsy at U.S. Academic Institutions. Curr Probl Diagn Radiol 48(5):462\u2013466","DOI":"10.1067\/j.cpradiol.2018.06.004"},{"issue":"1","key":"3299_CR44","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/modpathol.2015.128","volume":"29","author":"T Khoury","year":"2016","unstructured":"Khoury T, Kumar PR, Li Z, Karabakhtsian RG, Sanati S, Chen X et al (2016) Lobular neoplasia detected in MRI-guided core biopsy carries a high risk for upgrade: a study of 63 cases from four different institutions. Mod Pathol 29(1):25\u201333","journal-title":"Mod Pathol"},{"issue":"11","key":"3299_CR45","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.5858\/arpa.2016-0552-OA","volume":"141","author":"SB Jabbar","year":"2017","unstructured":"Jabbar SB, Lynch B, Seiler S, Hwang H, Sahoo S (2017) Pathologic Findings of Breast Lesions Detected on Magnetic Resonance Imaging. Arch Pathol Lab Med 141(11):1513\u20131522","journal-title":"Arch Pathol Lab Med"},{"key":"3299_CR46","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.clinimag.2021.03.026","volume":"78","author":"SA Chikarmane","year":"2021","unstructured":"Chikarmane SA, Harrison BT, Giess CS, Pinkney DM, Gombos EC (2021) Lobular neoplasia detected at MRI-guided biopsy: imaging findings and outcomes. Clin Imaging 78:171\u2013178","journal-title":"Clin Imaging"},{"issue":"3","key":"3299_CR47","doi-asserted-by":"publisher","first-page":"622","DOI":"10.2214\/AJR.20.23040","volume":"216","author":"AY Michaels","year":"2021","unstructured":"Michaels AY, Ginter PS, Dodelzon K, Naunheim MR, Abbey GN (2021) High-Risk Lesions Detected by MRI-Guided Core Biopsy: Upgrade Rates at Surgical Excision and Implications for Management. AJR Am J Roentgenol 216(3):622\u2013632","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"3299_CR48","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1245\/s10434-021-10827-z","volume":"29","author":"A Laws","year":"2022","unstructured":"Laws A, Katlin F, Nakhlis F, Chikarmane SA, Schnitt SJ, King TA (2022) Atypical Lobular Hyperplasia and Classic Lobular Carcinoma In Situ Can Be Safely Managed Without Surgical Excision. Ann Surg Oncol 29(3):1660\u20131667","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"3299_CR49","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s10549-017-4629-2","volume":"168","author":"H Schmidt","year":"2018","unstructured":"Schmidt H, Arditi B, Wooster M, Weltz C, Margolies L, Bleiweiss I et al (2018) Observation versus excision of lobular neoplasia on core needle biopsy of the breast. Breast Cancer Res Treat 168(3):649\u2013654","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"3299_CR50","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1245\/s10434-021-10828-y","volume":"29","author":"R Matar","year":"2022","unstructured":"Matar R, Sevilimedu V, Park A, King TA, Pilewskie M (2022) Comparison of Outcomes for Classic-Type Lobular Carcinoma In Situ Managed with Surgical Excision After Core Biopsy Versus Observation. Ann Surg Oncol 29(3):1670\u20131679","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"3299_CR51","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/cam4.223","volume":"3","author":"LP Middleton","year":"2014","unstructured":"Middleton LP, Sneige N, Coyne R, Shen Y, Dong W, Dempsey P et al (2014) Most lobular carcinoma in situ and atypical lobular hyperplasia diagnosed on core needle biopsy can be managed clinically with radiologic follow-up in a multidisciplinary setting. Cancer Med 3(3):492\u2013499","journal-title":"Cancer Med"},{"issue":"10","key":"3299_CR52","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1016\/j.humpath.2013.04.004","volume":"44","author":"SJ Shin","year":"2013","unstructured":"Shin SJ, Lal A, De Vries S, Suzuki J, Roy R, Hwang ES et al (2013) Florid lobular carcinoma in situ: molecular profiling and comparison to classic lobular carcinoma in situ and pleomorphic lobular carcinoma in situ. Hum Pathol 44(10):1998\u20132009","journal-title":"Hum Pathol"},{"issue":"3","key":"3299_CR53","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/PAS.0000000000001191","volume":"43","author":"ER Shamir","year":"2019","unstructured":"Shamir ER, Chen YY, Chu T, Pekmezci M, Rabban JT, Krings G (2019) Pleomorphic and Florid Lobular Carcinoma In Situ Variants of the Breast: A Clinicopathologic Study of 85 Cases With and Without Invasive Carcinoma From a Single Academic Center. Am J Surg Pathol 43(3):399\u2013408","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"3299_CR54","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s004280050469","volume":"436","author":"A Sapino","year":"2000","unstructured":"Sapino A, Frigerio A, Peterse JL, Arisio R, Coluccia C, Bussolati G (2000) Mammographically detected in situ lobular carcinomas of the breast. Virchows Arch 436(5):421\u2013430","journal-title":"Virchows Arch"},{"issue":"8","key":"3299_CR55","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/s41379-021-00796-9","volume":"34","author":"MG Kuba","year":"2021","unstructured":"Kuba MG, Murray MP, Coffey K, Calle C, Morrow M, Brogi E (2021) Morphologic subtypes of lobular carcinoma in situ diagnosed on core needle biopsy: clinicopathologic features and findings at follow-up excision. Mod Pathol 34(8):1495\u20131506","journal-title":"Mod Pathol"},{"issue":"11","key":"3299_CR56","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1097\/01.pas.0000213290.58283.82","volume":"30","author":"O Fadare","year":"2006","unstructured":"Fadare O, Dadmanesh F, Alvarado-Cabrero I, Snyder R, Stephen Mitchell J, Tot T et al (2006) Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: A clinicopathologic study of 18 cases. Am J Surg Pathol 30(11):1445\u20131453","journal-title":"Am J Surg Pathol"},{"key":"3299_CR57","doi-asserted-by":"crossref","unstructured":"Foschini MP, Miglio R, Fiore R, Baldovini C, Castellano I, Callagy G et al (2019) Eur J Surg Oncol 45(12):2279\u20132286","DOI":"10.1016\/j.ejso.2019.07.011"},{"issue":"7","key":"3299_CR58","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.5858\/2009-0300-OA.1","volume":"134","author":"ME Sullivan","year":"2010","unstructured":"Sullivan ME, Khan SA, Sullu Y, Schiller C, Susnik B (2010) Lobular carcinoma in situ variants in breast cores: potential for misdiagnosis, upgrade rates at surgical excision, and practical implications. Arch Pathol Lab Med 134(7):1024\u20131028","journal-title":"Arch Pathol Lab Med"},{"issue":"11","key":"3299_CR59","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1097\/PAS.0b013e3181b18a89","volume":"33","author":"YY Chen","year":"2009","unstructured":"Chen YY, Hwang ES, Roy R, DeVries S, Anderson J, Wa C et al (2009) Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast. Am J Surg Pathol 33(11):1683\u20131694","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"3299_CR60","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1097\/PAS.0000000000001493","volume":"44","author":"E Zhong","year":"2020","unstructured":"Zhong E, Solomon JP, Cheng E, Baum J, Song W, Hoda SA (2020) Apocrine Variant of Pleomorphic Lobular Carcinoma In Situ: Further Clinical, Histopathologic, Immunohistochemical, and Molecular Characterization of an Emerging Entity. Am J Surg Pathol 44(8):1092\u20131103","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"3299_CR61","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1097\/01.MP.0000030450.20581.E3","volume":"15","author":"N Sneige","year":"2002","unstructured":"Sneige N, Wang J, Baker BA, Krishnamurthy S, Middleton LP (2002) Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases. Mod Pathol 15(10):1044\u20131050","journal-title":"Mod Pathol"},{"issue":"1","key":"3299_CR62","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/tbj.12843","volume":"24","author":"CE Fasola","year":"2018","unstructured":"Fasola CE, Chen JJ, Jensen KC, Allison KH, Horst KC (2018) Characteristics and clinical outcomes of pleomorphic lobular carcinoma in situ of the breast. Breast J 24(1):66\u201369","journal-title":"Breast J"},{"issue":"13","key":"3299_CR63","doi-asserted-by":"publisher","first-page":"4263","DOI":"10.1245\/s10434-015-4552-x","volume":"22","author":"MR Flanagan","year":"2015","unstructured":"Flanagan MR, Rendi MH, Calhoun KE, Anderson BO, Javid SH (2015) Pleomorphic Lobular Carcinoma In Situ: Radiologic-Pathologic Features and Clinical Management. Ann Surg Oncol 22(13):4263\u20134269","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"3299_CR64","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1111\/his.12353","volume":"64","author":"T Khoury","year":"2014","unstructured":"Khoury T, Karabakhtsian RG, Mattson D, Yan L, Syriac S, Habib F et al (2014) Pleomorphic lobular carcinoma in situ of the breast: clinicopathological review of 47 cases. Histopathology 64(7):981\u2013993","journal-title":"Histopathology"},{"issue":"2","key":"3299_CR65","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s10549-017-4334-1","volume":"165","author":"M De Brot","year":"2017","unstructured":"De Brot M, KoslowMautner S, Muhsen S, Andrade VP, Mamtani A, Murray M et al (2017) Pleomorphic lobular carcinoma in situ of the breast: a single institution experience with clinical follow-up and centralized pathology review. Breast Cancer Res Treat 165(2):411\u2013420","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"3299_CR66","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1245\/s10434-018-6591-6","volume":"25","author":"AA Desai","year":"2018","unstructured":"Desai AA, Jimenez RE, Hoskin TL, Day CN, Boughey JC, Hieken TJ (2018) Treatment Outcomes for Pleomorphic Lobular Carcinoma In Situ of the Breast. Ann Surg Oncol 25(10):3064\u20133068","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"3299_CR67","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1245\/s10434-018-6937-0","volume":"26","author":"F Nakhlis","year":"2019","unstructured":"Nakhlis F, Harrison BT, Giess CS, Lester SC, Hughes KS, Coopey SB et al (2019) Evaluating the Rate of Upgrade to Invasive Breast Cancer and\/or Ductal Carcinoma In Situ Following a Core Biopsy Diagnosis of Non-classic Lobular Carcinoma In Situ. Ann Surg Oncol 26(1):55\u201361","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"3299_CR68","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1097\/PAS.0b013e31817dc3a6","volume":"32","author":"M Chivukula","year":"2008","unstructured":"Chivukula M, Haynik DM, Brufsky A, Carter G, Dabbs DJ (2008) Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile. Am J Surg Pathol 32(11):1721\u20131726","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"3299_CR69","doi-asserted-by":"publisher","first-page":"e449","DOI":"10.1016\/j.clbc.2017.10.004","volume":"18","author":"T Guo","year":"2018","unstructured":"Guo T, Wang Y, Shapiro N, Fineberg S (2018) Pleomorphic Lobular Carcinoma in Situ Diagnosed by Breast Core Biopsy: Clinicopathologic Features and Correlation With Subsequent Excision. Clin Breast Cancer 18(4):e449\u2013e454","journal-title":"Clin Breast Cancer"},{"issue":"3","key":"3299_CR70","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/j.1365-2559.2010.03634.x","volume":"57","author":"PJ Carder","year":"2010","unstructured":"Carder PJ, Shaaban A, Alizadeh Y, Kumarasuwamy V, Liston JC, Sharma N (2010) Screen-detected pleomorphic lobular carcinoma in situ (PLCIS): risk of concurrent invasive malignancy following a core biopsy diagnosis. Histopathology 57(3):472\u2013478","journal-title":"Histopathology"},{"key":"3299_CR71","doi-asserted-by":"crossref","unstructured":"Singh K, Sung CJ, Quddus MR (2020) Descriptive study comparing outcomes of classic and nonclassic lobular carcinoma in situ (florid and pleomorphic) initially diagnosed on core needle biopsy. Breast J","DOI":"10.1111\/tbj.14085"},{"key":"3299_CR72","doi-asserted-by":"crossref","unstructured":"Cserni G, Floris G, Koufopoulos N, Kovacs A, Nonni A, Regitnig P, et al. (2017) Invasive lobular carcinoma with extracellular mucin production-a novel pattern of lobular carcinomas of the breast. Clinico-pathological description of eight cases. Virchows Arch 471(1):3\u201312","DOI":"10.1007\/s00428-017-2147-6"},{"key":"3299_CR73","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.humpath.2018.04.026","volume":"78","author":"K Singh","year":"2018","unstructured":"Singh K, Paquette C, Kalife ET, Wang Y, Mangray S, Quddus MR et al (2018) Evaluating agreement, histological features, and relevance of separating pleomorphic and florid lobular carcinoma in situ subtypes. Hum Pathol 78:163\u2013170","journal-title":"Hum Pathol"},{"key":"3299_CR74","unstructured":"Royal College of Pathologists. Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening.\u00a0https:\/\/www.rcpath.org\/uploads\/assets\/4b16f19c-f7bd-456c-b212f557f8040f66\/G150-Non-op-reporting-breast-cancer-screening.pdf2021. Accessed 10 Mar 2022"},{"key":"3299_CR75","unstructured":"European guidelines for quality assurance in breast cancer screening and diagnosis Fourth Edition,\u00a02006.\u00a0https:\/\/screening.iarc.fr\/doc\/ND7306954ENC_002.pdf. Accessed 10 Mar 2022"},{"issue":"7","key":"3299_CR76","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/s41379-020-0459-6","volume":"33","author":"BT Harrison","year":"2020","unstructured":"Harrison BT, Nakhlis F, Dillon DA, Soong TR, Garcia EP, Schnitt SJ et al (2020) Genomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERRB3 alterations. Mod Pathol 33(7):1287\u20131297","journal-title":"Mod Pathol"},{"issue":"6","key":"3299_CR77","doi-asserted-by":"publisher","first-page":"737","DOI":"10.5858\/2010-0204-OA.1","volume":"135","author":"E Downs-Kelly","year":"2011","unstructured":"Downs-Kelly E, Bell D, Perkins GH, Sneige N, Middleton LP (2011) Clinical implications of margin involvement by pleomorphic lobular carcinoma in situ. Arch Pathol Lab Med 135(6):737\u2013743","journal-title":"Arch Pathol Lab Med"},{"key":"3299_CR78","unstructured":"Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) Breast. The AJCC Cancer Staging Manual. 7th Edition ed. New York, NY: Springer New York Dordrecht Heidelberg London"},{"key":"3299_CR79","doi-asserted-by":"crossref","unstructured":"Hortobagyi GN, Connolly JL, D'Orsi CJ, Edge SB, Mittendorf EA, Hugo HS, et al. (2017) Breast. The AJCC Cancer Staging Manual. 8th edn, pp 589\u2013628","DOI":"10.1007\/978-3-319-40618-3_48"},{"key":"3299_CR80","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/annonc\/mdz173","volume":"30","author":"F Cardoso","year":"2019","unstructured":"Cardoso F, Kyrickides S, Ohno S, Penault-Lorca F, Poortmans P, Rubio IT, a, (2019) Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 30:1194\u20131220","journal-title":"Ann Oncol"},{"issue":"5","key":"3299_CR81","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/PAS.0b013e318158d6c5","volume":"32","author":"L Da Silva","year":"2008","unstructured":"Da Silva L, Parry S, Reid L, Keith P, Waddell N, Kossai M et al (2008) Aberrant expression of E-cadherin in lobular carcinomas of the breast. Am J Surg Pathol 32(5):773\u2013783","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"3299_CR82","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/his.12869","volume":"68","author":"R Canas-Marques","year":"2016","unstructured":"Canas-Marques R, Schnitt SJ (2016) E-cadherin immunohistochemistry in breast pathology: uses and pitfalls. Histopathology 68(1):57\u201369","journal-title":"Histopathology"},{"key":"3299_CR83","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.humpath.2020.06.002","volume":"102","author":"A Grabenstetter","year":"2020","unstructured":"Grabenstetter A, Mohanty AS, Rana S, Zehir A, Brannon AR, D\u2019Alfonso TM et al (2020) E-cadherin immunohistochemical expression in invasive lobular carcinoma of the breast: correlation with. Hum Pathol 102:44\u201353","journal-title":"Hum Pathol"},{"issue":"7","key":"3299_CR84","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/PAS.0b013e3182918a2b","volume":"37","author":"DJ Dabbs","year":"2013","unstructured":"Dabbs DJ, Schnitt SJ, Geyer FC, Weigelt B, Baehner FL, Decker T et al (2013) Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry. Am J Surg Pathol 37(7):e1\u2013e11","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"3299_CR85","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/01.pas.0000213386.63160.3f","volume":"31","author":"DJ Dabbs","year":"2007","unstructured":"Dabbs DJ, Bhargava R, Chivukula M (2007) Lobular versus ductal breast neoplasms: the diagnostic utility of p120 catenin. Am J Surg Pathol 31(3):427\u2013437","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"3299_CR86","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10549-004-4493-8","volume":"90","author":"SK Mohsin","year":"2005","unstructured":"Mohsin SK, O\u2019Connell P, Allred DC, Libby AL (2005) Biomarker profile and genetic abnormalities in lobular carcinoma in situ. Breast Cancer Res Treat 90(3):249\u2013256","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"3299_CR87","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.molonc.2015.11.001","volume":"10","author":"RA Sakr","year":"2016","unstructured":"Sakr RA, Schizas M, Carniello JV, Ng CK, Piscuoglios S, Giri D et al (2016) Targeted captire massive parallel sequencing analysis of LCIS and invasive lobular cancer. Mol Oncol 10(2):360\u2013270","journal-title":"Mol Oncol"},{"issue":"1","key":"3299_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/path.1806","volume":"207","author":"JS Reis-Filho","year":"2005","unstructured":"Reis-Filho JS, Simpson PT, Jones C, Steele D, Mackay A, Iravani M et al (2005) Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity. J Pathol 207(1):1\u201313","journal-title":"J Pathol"},{"issue":"5","key":"3299_CR89","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/gcc.20756","volume":"49","author":"V Boldt","year":"2010","unstructured":"Boldt V, Stacher E, Halbwedl I, Popper H, Hultschig C, Moinfar F et al (2010) Positioning of necrotic lobular intraepithelial neoplasias (LIN, grade 3) within the sequence of breast carcinoma progression. Genes Chromosomes Cancer 49(5):463\u2013470","journal-title":"Genes Chromosomes Cancer"},{"issue":"6","key":"3299_CR90","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41379-019-0449-8","volume":"33","author":"ER Shamir","year":"2020","unstructured":"Shamir ER, Chen YY, Krings G (2020) Genetic analysis of pleomorphic and florid lobular carcinoma in situ variants: frequent ERBB2\/ERBB3 alterations and clonal relationship to classic lobular carcinoma in situ and invasive lobular carcinoma. Mod Pathol 33(6):1078\u20131091","journal-title":"Mod Pathol"},{"issue":"3","key":"3299_CR91","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1245\/s10434-015-4922-4","volume":"23","author":"F Nakhlis","year":"2016","unstructured":"Nakhlis F, Gilmore L, Gelman R, Bedrosian I, Ludwig K, Hwang ES et al (2016) Incidence of Adjacent Synchronous Invasive Carcinoma and\/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020). Ann Surg Oncol 23(3):722\u2013728","journal-title":"Ann Surg Oncol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-022-03299-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-022-03299-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-022-03299-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T15:27:23Z","timestamp":1700580443000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-022-03299-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,14]]},"references-count":91,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3299"],"URL":"https:\/\/doi.org\/10.1007\/s00428-022-03299-3","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,14]]},"assertion":[{"value":"21 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is based on review of published literature and complies with the Institutional Ethical Standards","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"E. B. has no conflict of interest to declare","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}